Literature DB >> 30794787

Predictive Factors for the Rate of Visual Field Progression in the Advanced Imaging for Glaucoma Study.

Xinbo Zhang1, Richard K Parrish2, David S Greenfield2, Brian A Francis3, Rohit Varma4, Joel S Schuman5, Ou Tan1, David Huang6.   

Abstract

PURPOSE: To investigate predictive factors associated with the rate of visual field (VF) loss in open-angle glaucoma.
DESIGN: Prospective multicenter cohort study.
METHODS: Perimetric glaucoma patients of the Advanced Imaging for Glaucoma study were selected for analysis if they had 9 completed visits. Confirmed rapid significant progression (CRSP) of VF was defined as a significant (P < 0.05) negative VF index (VFI) slope of -1%/year or a mean deviation slope of -0.5 dB/year, confirmed at 2 consecutive follow-up visits. Slow progression was defined as VFI slope greater than -0.5%/year or a mean deviation slope of -0.25 dB/year. Fourier-domain optical coherence tomography (FD-OCT) measured optic disc, peripapillary retinal nerve fiber layer (NFL), and macular ganglion cell complex (GCC) thicknesses. Logistic regression was used to identify baseline predictors for CRSP and slow progression. Linear regression was used to identify baseline predictors for the VFI and mean deviation slope.
RESULTS: Eyes (n = 150) of 103 participants were included. Slow progression was observed in 80 eyes (53.3%) and CRSP in 23 eyes (15.3%). Larger NFL and GCC baseline focal loss volume (FLV), thinner central corneal thickness, and lower VFI were significant (P < 0.05) baseline predictors of more rapid progression on univariate analysis. The predictor with the highest odds ratio (OR) was NFL-FLV, which was also the most significant non-VF predictor in the multivariate analysis. Eyes with NFL-FLV >8.5% had an OR of 2.67 for CRSP and 0.42 for slow progression. Disc hemorrhage during the follow-up was also important, with an OR of 2.61 for CRSP and 0.23 for slow progression for each occurrence.
CONCLUSIONS: Focal loss measured by FD-OCT or VF along with CCT are strong baseline predictors for the rate of glaucoma progression.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30794787      PMCID: PMC6548618          DOI: 10.1016/j.ajo.2019.02.015

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  41 in total

1.  Effect of treatment on the rate of visual field change in the ocular hypertension treatment study observation group.

Authors:  Carlos Gustavo De Moraes; Shaban Demirel; Stuart K Gardiner; Jeffrey M Liebmann; George A Cioffi; Robert Ritch; Mae O Gordon; Michael A Kass
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-04-02       Impact factor: 4.799

2.  Does optic nerve head size variation affect circumpapillary retinal nerve fiber layer thickness measurement by optical coherence tomography?

Authors:  David Huang; Vikas Chopra; Ake Tzu-Hui Lu; Ou Tan; Brian Francis; Rohit Varma
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-07-27       Impact factor: 4.799

3.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

4.  Advanced imaging for glaucoma study: design, baseline characteristics, and inter-site comparison.

Authors:  Phuc V Le; Xinbo Zhang; Brian A Francis; Rohit Varma; David S Greenfield; Joel S Schuman; Nils Loewen; David Huang
Journal:  Am J Ophthalmol       Date:  2014-11-08       Impact factor: 5.258

5.  A visual field index for calculation of glaucoma rate of progression.

Authors:  Boel Bengtsson; Anders Heijl
Journal:  Am J Ophthalmol       Date:  2008-02       Impact factor: 5.258

6.  Natural history of open-angle glaucoma.

Authors:  Anders Heijl; Boel Bengtsson; Leslie Hyman; M Cristina Leske
Journal:  Ophthalmology       Date:  2009-10-24       Impact factor: 12.079

7.  Visual field progression in the Collaborative Initial Glaucoma Treatment Study the impact of treatment and other baseline factors.

Authors:  David C Musch; Brenda W Gillespie; Paul R Lichter; Leslie M Niziol; Nancy K Janz
Journal:  Ophthalmology       Date:  2008-11-18       Impact factor: 12.079

8.  Detection of macular ganglion cell loss in glaucoma by Fourier-domain optical coherence tomography.

Authors:  Ou Tan; Vikas Chopra; Ake Tzu-Hui Lu; Joel S Schuman; Hiroshi Ishikawa; Gadi Wollstein; Rohit Varma; David Huang
Journal:  Ophthalmology       Date:  2009-09-10       Impact factor: 12.079

9.  Effect of Signal Intensity on Measurement of Ganglion Cell Complex and Retinal Nerve Fiber Layer Scans in Fourier-Domain Optical Coherence Tomography.

Authors:  Xinbo Zhang; Shawn M Iverson; Ou Tan; David Huang
Journal:  Transl Vis Sci Technol       Date:  2015-10-01       Impact factor: 3.283

Review 10.  Suitability of the Visual Field Index according to Glaucoma Severity.

Authors:  Marina Cc Sousa; Luis G Biteli; Syril Dorairaj; Jessica S Maslin; Mauro T Leite; Tiago S Prata
Journal:  J Curr Glaucoma Pract       Date:  2016-02-02
View more
  11 in total

1.  Risk factors for visual field progression in newly diagnosed exfoliation glaucoma patients in Sweden.

Authors:  Marcelo Ayala
Journal:  Sci Rep       Date:  2022-06-24       Impact factor: 4.996

2.  Border tissue morphology is associated with the pattern of visual field progression in open-angle glaucoma.

Authors:  Hyun Joo Kee; Jong Chul Han; Eui Do Song; Eui Jun Choi; Dong Ook Son; Eun Jung Lee; Yoon Kyoung Jang; Changwon Kee
Journal:  Sci Rep       Date:  2022-07-14       Impact factor: 4.996

3.  Measuring Glaucomatous Focal Perfusion Loss in the Peripapillary Retina Using OCT Angiography.

Authors:  Aiyin Chen; Liang Liu; Jie Wang; Pengxiao Zang; Beth Edmunds; Lorinna Lombardi; Ellen Davis; John C Morrison; Yali Jia; David Huang
Journal:  Ophthalmology       Date:  2019-11-08       Impact factor: 12.079

4.  Special Commentary: Using Clinical Decision Support Systems to Bring Predictive Models to the Glaucoma Clinic.

Authors:  Brian C Stagg; Joshua D Stein; Felipe A Medeiros; Barbara Wirostko; Alan Crandall; M Elizabeth Hartnett; Mollie Cummins; Alan Morris; Rachel Hess; Kensaku Kawamoto
Journal:  Ophthalmol Glaucoma       Date:  2020-08-15

5.  Evaluating the Correlation between Alzheimer's Amyloid-β Peptides and Glaucoma in Human Aqueous Humor.

Authors:  Francesca Cappelli; Francesca Caudano; Maria Marenco; Valeria Testa; Alessandro Masala; Daniele Sindaco; Angelo Macrì; Carlo E Traverso; Michele Iester; Roberta Ricciarelli
Journal:  Transl Vis Sci Technol       Date:  2020-04-25       Impact factor: 3.283

Review 6.  Discovery and clinical translation of novel glaucoma biomarkers.

Authors:  Gala Beykin; Anthony M Norcia; Vivek J Srinivasan; Alfredo Dubra; Jeffrey L Goldberg
Journal:  Prog Retin Eye Res       Date:  2020-07-10       Impact factor: 21.198

7.  Focal Loss Analysis of Nerve Fiber Layer Reflectance for Glaucoma Diagnosis.

Authors:  Ou Tan; Liang Liu; Qisheng You; Jie Wang; Aiyin Chen; Eliesa Ing; John C Morrison; Yali Jia; David Huang
Journal:  Transl Vis Sci Technol       Date:  2021-05-03       Impact factor: 3.283

8.  Comparison of visual field progression in new-diagnosed primary open-angle and exfoliation glaucoma patients in Sweden.

Authors:  Marcelo Ayala
Journal:  BMC Ophthalmol       Date:  2020-08-05       Impact factor: 2.209

Review 9.  Ganglion Cell Complex Analysis in Glaucoma Patients: What Can It Tell Us?

Authors:  Gianluca Scuderi; Serena Fragiotta; Luca Scuderi; Clemente Maria Iodice; Andrea Perdicchi
Journal:  Eye Brain       Date:  2020-01-31

10.  Relationship between Oxidative Stress Biomarkers and Visual Field Progression in Patients with Primary Angle Closure Glaucoma.

Authors:  Shengjie Li; Mingxi Shao; Yingzhu Li; Xiaojuan Li; Yani Wan; Xinghuai Sun; Wenjun Cao
Journal:  Oxid Med Cell Longev       Date:  2020-08-05       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.